News & Perspective

Aug 24, 2005

Aug 24, 2005

Roche to give flu drug to WHO to fight pandemic

(CIDRAP News) – The Swiss drug company Roche has pledged to give the World Health Organization (WHO) enough doses of the antiviral drug oseltamivir (Tamiflu) to treat 3 million people, in the hope that it could help to stave off or delay an influenza pandemic.

Aug 26, 2005

Aug 26, 2005

Avian flu virus infected civets in Vietnam

(CIDRAP News) – Reports today said three rare palm civets that recently died in captivity in Vietnam were infected with an H5N1 avian influenza virus, adding another species to the list of those susceptible to the pathogen.

Sep 30, 2005

Sep 30, 2005

Senate approves $4 billion to prepare for flu pandemic

(CIDRAP News) – The US Senate voted yesterday to provide $4 billion for antiviral drugs and other measures to prepare for a feared influenza pandemic, but whether the measure would clear Congress was uncertain.

Mar 24, 2006

Mar 24, 2006

Two die of avian flu in Cambodia, China

(CIDRAP News) – Avian influenza has killed a 3-year-old girl in Cambodia and a 29-year-old woman in China, pushing the global toll from the H5N1 virus to 105 deaths out of 186 cases, the World Health Organization announced today.

Feb 01, 2008

Feb 01, 2008

Europe says Tamiflu-resistant virus seen in 9 countries

(CIDRAP News) – European officials yesterday reported more evidence that one of the three types of seasonal influenza viruses is showing resistance to oseltamivir (Tamiflu) and said this represents the first clear sign that the resistant variant can spread.

Sep 23, 2010

Sep 23, 2010

Probe of suspected vaccine-narcolepsy link to take months

(CIDRAP News) – The European Medicine Agency (EMA) said today it is not clear if there is any link between narcolepsy cases and the Pandemrix vaccine for 2009 H1N1 influenza, and it will take 3 to 6 months to investigate the possibility fully.

Oct 06, 2010

Oct 06, 2010

Trial answers some, not all, questions on cell-based flu vaccines

(CIDRAP News) – A new report says that a cell culture derived influenza vaccine and a conventional egg-based vaccine both proved effective in a large international clinical trial, offering support for those who contend that cell-based vaccines should become an important part of flu vaccine supplies in coming years.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»